MPCs as a commodity. Bleeding obvious., page-2

  1. 6,154 Posts.
    lightbulb Created with Sketch. 1096
    @benelong

    Brilliant mate. Ive stated before that MPC's are like millions of homing cells that find the damaged tissue. They just know where to go.

    Attaching molecules to the tracking devices has huge potential.

    Hence the partnership with Cartherics for cancer. They too need Mesoblast as well.

    NEW YORK and MELBOURNE, Australia, May 29, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR-T cells armed with multiple targeting receptors for use in solid cancers. Off the shelf CAR-T therapies have the potential to reduce costs dramatically and open up this very effective treatment to millions of cancer patients across the world. The initial targets are relapsed ovarian and gastric cancers. Mesoblast and Cartherics will jointly own the intellectual property produced using their combined technologies.

    https://globenewswire.com/news-rele...-based-Immunotherapies-for-Solid-Cancers.html
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.63
Change
0.015(0.93%)
Mkt cap ! $2.082B
Open High Low Value Volume
$1.63 $1.67 $1.61 $6.975M 4.265M

Buyers (Bids)

No. Vol. Price($)
1 707 $1.63
 

Sellers (Offers)

Price($) Vol. No.
$1.64 7320 2
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.